ABVC BioPharma, Inc. (ABVC)
NASDAQ·Healthcare·Biotechnology
$1.08
-0.07%
Mkt Cap $21.16M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | — | -$795.95K | — | — | -$0.12 | — | — | — |
| Q4 2025 Oct 31, 2025 | — | $795.95K | — | — | -$0.05 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | — | -$0.13 | — | — | — |
| Q2 2025 Apr 30, 2025 | — | — | — | — | -$0.06 | — | — | — |
| Q2 2025 Apr 15, 2025 | — | $1.97K | — | — | $0.04 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | $389.28K | — | — | -$0.02 | — | — | — |
| Q3 2024 Aug 14, 2024 | — | $117.14K | — | — | -$0.09 | — | — | — |
| Q1 2024 Mar 13, 2024 | — | $2.17K | — | -$0.50 | -$0.35 | +30.00% | — | — |
| Q4 2023 Nov 15, 2023 | $300.00K | $15.88K | -94.71% | -$0.40 | -$0.82 | -105.00% | — | — |
| Q3 2023 Aug 14, 2023 | $300.00K | $6.11K | -97.96% | -$0.60 | -$0.68 | -13.33% | — | — |
| Q2 2023 May 15, 2023 | — | $128.27K | — | -$0.50 | -$0.60 | -20.00% | — | — |
| Q1 2023 Mar 31, 2023 | $10.00K | $588.99K | +5789.94% | -$1.90 | -$1.50 | +21.05% | — | — |
| Q4 2022 Nov 14, 2022 | $26.18K | $42.27K | +61.48% | -$2.00 | -$1.10 | +45.00% | — | — |
| Q3 2022 Aug 15, 2022 | $25.92K | $312.86K | +1107.16% | -$2.00 | -$0.60 | +70.00% | — | — |
| Q2 2022 May 16, 2022 | — | $25.66K | — | — | -$2.00 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | -$37.79K | — | -$0.04 | -$0.31 | -675.00% | — | — |
| Q4 2021 Nov 15, 2021 | $144.44K | $99.00K | -31.46% | -$0.40 | -$0.70 | -75.00% | — | — |
| Q3 2021 Aug 12, 2021 | $263.00K | $31.44K | -88.05% | -$0.04 | -$0.81 | -1918.30% | — | — |
| Q2 2021 May 10, 2021 | — | $263.15K | — | — | -$0.46 | — | — | — |
| Q1 2021 Mar 16, 2021 | — | $62.19K | — | -$0.10 | -$0.24 | -140.00% | — | — |